Cargando…
Associations of [(18)F]-APN-1607 Tau PET Binding in the Brain of Alzheimer’s Disease Patients With Cognition and Glucose Metabolism
Molecular imaging of tauopathies is complicated by the differing specificities and off-target binding properties of available radioligands for positron emission tomography (PET). [(18)F]-APN-1607 ([(18)F]-PM-PBB3) is a newly developed PET tracer with promising properties for tau imaging. We aimed to...
Autores principales: | Lu, Jiaying, Bao, Weiqi, Li, Ming, Li, Ling, Zhang, Zhengwei, Alberts, Ian, Brendel, Matthias, Cumming, Paul, Lu, Huimeng, Xiao, Zhenxu, Zuo, Chuantao, Guan, Yihui, Zhao, Qianhua, Rominger, Axel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338611/ https://www.ncbi.nlm.nih.gov/pubmed/32694971 http://dx.doi.org/10.3389/fnins.2020.00604 |
Ejemplares similares
-
Parametric Estimation of Reference Signal Intensity for Semi-Quantification of Tau Deposition: A Flortaucipir and [(18)F]-APN-1607 Study
por: Zhang, Huiwei, et al.
Publicado: (2021) -
Cryo-EM structures of tau filaments from Alzheimer’s disease with PET ligand APN-1607
por: Shi, Yang, et al.
Publicado: (2021) -
Correction to: Cryo-EM structures of tau filaments from Alzheimer’s disease with PET ligand APN-1607
por: Shi, Yang, et al.
Publicado: (2021) -
Visual reading for [(18)F]Florzolotau ([(18)F]APN-1607) tau PET imaging in clinical assessment of Alzheimer’s disease
por: Lin, Huan-Chun, et al.
Publicado: (2023) -
(18)F-APN-1607 Tau Positron Emission Tomography Imaging for Evaluating Disease Progression in Alzheimer’s Disease
por: Xu, Xiaojun, et al.
Publicado: (2022)